Jan. 08 Pre-market Movers Board: Boeing plunges 8% premarket after an explosion occurred on Boeing 737 MAX 9 last Friday

Seize the market opportunities with us at 8:45 every morning, and don't forget to check our "Lunchtime Movers Board" at 12:00.

Premarket Gainers: Harpoon, Vincerx, Heron, Annexon, Molecular

HARP:

Harpoon Therapeutics rockets 102% premarket after reported Merck in talks to buy the Co. for $700M.

VINC:

Vincerx Pharma soars 59% premarket after announcing compelling clinical efficacy of Enitociclib in combination with Venetoclax and prednisone in lymphoma.

HRTX:

Heron Therapeutics surges 12% premarket after announcing partnership with Crosslink life sciences to expand promotional effort for ZYNRELEF.

ANNX:

Annexon climbs 10% premarket after outlines priorities with late-stage clinical milestones across upstream complement portfolio for autoimmune, ophthalmic and neurodegenerative diseases.

MOLN:

Molecular spikes 5% as the Co. to provide updates at 42nd annual JPM Healthcare conference.

Premarket Losers: LumiraDx, Spirit, Boeing, Alaska Air,  XPeng

LMDX: LumiraDx plunges 29% premarket after announcing its securities will be suspended from trading on Nasdaq.

SPR:

Spirit Aerosystems drops 15% premarket under the effect of Boeing 737 Max explosion.

BA:

Boeing plunges 8% premarket after The FAA required all Boeing 737 MAX 9 aircraft operated within US to be temporarily grounded and undergo safety inspections.

ALK:

Alaska Air sinks 5% premarket after an explosion occurred on one of the company's Boeing 737 MAX 9 aircraft last Friday.

XPEV: 

XPeng sinks 5% premarket after JPM sold HK$334M of the Co.'s HK-listed shares.

$HARP(HARP)$VINC(VINC)$HRTX(HRTX)$ANNX(ANNX)$MOLN(MOLN)$LMDX(LMDX)$SPR(SPR)$BA(BA)$ALK(ALK)$XPEV(XPEV)